A myeloma survivor in long remission shares how research, expert care and advocacy turned fear into hope as more patients ...

Minimal residual disease (MRD) refers to the small number of myeloma cells that may remain after treatment and are not detectable using conventional response criteria. In multiple myeloma, MRD ...

Explore the evolving landscape of myeloma treatment, focusing on maintenance therapies and patient experiences with innovative drug combinations. Maintenance therapy is a long-term phase of multiple ...

Cancer survival reaches 70% at 5 years, as targeted and immunotherapies boost outcomes and shift care toward survivorship and long-term quality of life.

Palliative care that recognizes patient goals and values is essential, starting at diagnos ...

How Does Multiple Myeloma Impact the Kidneys? Multiple myeloma is a cancer of plasma cells, a type of immune cell found in bone marrow. Healthy plasma cells make proteins called antibodies to fight ...

She’s a local legend, and at 84, she’s only getting better. Ellen Hart, the larger-than-life owner of Broadway’s iconic Ellen ...

It’s not often that researchers get to share encouraging news when it comes to cancer. That’s why the recent announcement ...

However, with these recommendations, patients with advanced blood cancers use hospice much less than patients with solid tumors. These advanced cancers include leukemia, lymphoma and multiple myeloma, ...

The management of treatment side effects can expand caregiver duties significantly, and can involve working more closely with the healthcare team. The symptoms related to multiple myeloma, such as ...

Multiple myeloma was once viewed as an incurable diagnosis, but Ameet Patel, MD, of Florida Cancer Specialists & Research ...